{
    "2019-05-20": [
        [
            {
                "time": "2023-10-01",
                "original_text": "SPDR S&P Dividend ETF Experiences Big Outflow",
                "features": {
                    "keywords": [
                        "SPDR",
                        "S&P",
                        "Dividend",
                        "ETF",
                        "Big",
                        "Outflow"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Drugmakersâ€™ lobbying spending at 10-year high as Washington targets soaring prices",
                "features": {
                    "keywords": [
                        "Drugmakers'",
                        "lobbying",
                        "spending",
                        "10-year",
                        "high",
                        "Washington",
                        "targets",
                        "soaring",
                        "prices"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie's Brain Cancer Candidate Fails in Phase III Study",
                "features": {
                    "keywords": [
                        "AbbVie's",
                        "Brain",
                        "Cancer",
                        "Candidate",
                        "Fails",
                        "Phase",
                        "III",
                        "Study"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}